Aethl Bio Appoints Dr. Joseph Maroon to Scientific Advisory Board

Feb 6, 2026 Aethl Bio, a Pittsburgh-based biotechnology company developing next-generation platforms at the intersection of wound care and wellness, today announced the appointment of Dr. Joseph Maroon, MD, FACS, to its Scientific Advisory Board.

READ PRESS RELEASE HERE

Aethl Bio is developing advanced oxygen-based solutions designed to address foundational limitations in healing and recovery across chronic wound care and wellness applications. The company’s platform technology is engineered to deliver biologically relevant oxygen in formats intended to support tissue repair, resilience, and long-term health.

“Throughout my career, I’ve focused on therapies that address inflammation and the root causes of injury and degeneration,” said Dr. Maroon. “Aethl Bio’s approach aligns with that philosophy. Their platform represents a thoughtful and promising advancement in how we think about oxygen, healing, and recovery.”

Dr. Maroon’s appointment further strengthens Aethl Bio’s scientific leadership as the company advances pre-clinical validation, regulatory strategy, and clinical partnerships. His guidance will support platform development, translational research strategy, and long-term clinical positioning.

About Aethl Bio, Inc.

Aethl Bio is a Pittsburgh-based biotechnology company developing advanced oxygen-based solutions for chronic and complex conditions. Its proprietary Hyper-oxygenated Solution Platform is designed to deliver biologically relevant oxygen in formats intended to support healing and recovery across medical and wellness applications.

For press inquiries:

Zach Richert
Aethl Bio, Inc.
+1 412-212-6563
media@aethl.com